Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
48 A recent phase III RCT of cenicriviroc in NASH patients (AURORA) was terminated early, due to a lack of benefit based on the part 1 results
If you dont qualify, patient assistance programs may help reduce costs
The body will lose fat from the body and the face and is not selective regarding where fat is lost
IGF-1 LR3 (insulin-like growth factor-1 long arginine 3) is a synthetically modified derivative of insulin-like growth factor-1, which is produced in the liver in response to growth hormone endocrine stimulus
Total spend
This medication, originally developed for managing type 2 diabetes, is now widely prescribed for weight loss due to its ability to regulate appetite and improve blood sugar levels
US$ 29.39
US$ 24.43
US$ 28.68
